Literature DB >> 11322375

Early prognostic factors of infants with chronic renal failure caused by renal dysplasia.

K Ismaili1, T Schurmans, K M Wissing, M Hall, C Van Aelst, F Janssen.   

Abstract

Renal dysplasia (RD) is a common cause of chronic renal failure (CRF) in children. The evolution towards end-stage renal failure is unpredictable due to the paucity of early prognostic factors. In order to identify early prognostic clinical criteria, we have retrospectively analyzed renal function and growth in 11 infants with RD and CRF from birth up to 4 years of age. Children with obstructive RD were not included. Glomerular filtration rate (GFR) was estimated from Schwartz formula. In infants with a GFR below 15 ml/min per 1.73 m2 at 6 months of age (group A, n=5), kidney function did not further improve; 4 reached end-stage renal failure between 8 months and 6 years of age. In contrast, infants with a GFR above 15 ml/min per 1.73 m2 at 6 months of age (group B, n=6) experienced a significant improvement in renal function during follow-up, and none required renal replacement therapy. During the first 3 months of life all infants with RD and CRF developed severe growth retardation. Between 6 months and 4 years of age, children from group B grew significantly better than those from group A. In conclusion, our experience suggests that GFR, estimated from Schwartz formula at 6 months of age, is a useful prognostic factor in infants with RD and CRF. Infants with a GFR below 15 ml/min per 1.73 m2 are at risk of severe growth delay and the need for early renal replacement therapy, whereas those with a GFR above 15 ml/min per 1.73 m2 have a relatively favorable long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322375     DOI: 10.1007/s004670000539

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  9 in total

1.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

2.  Clinical characteristics and outcomes of children with stage 3-5 chronic kidney disease.

Authors:  Tran Thi Mong Hiep; Khalid Ismaili; Frederic Collart; Rita Van Damme-Lombaerts; Nathalie Godefroid; Marie-Sophie Ghuysen; Koen Van Hoeck; Ann Raes; Françoise Janssen; Annie Robert
Journal:  Pediatr Nephrol       Date:  2010-02-11       Impact factor: 3.714

3.  Growth impairment shows an age-dependent pattern in boys with chronic kidney disease.

Authors:  Miroslav Zivicnjak; Doris Franke; Guido Filler; Dieter Haffner; Kerstin Froede; Richard Nissel; Sanny Haase; Gisela Offner; Jochen H H Ehrich; Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2006-11-28       Impact factor: 3.714

4.  HNF1B and PAX2 mutations are a common cause of renal hypodysplasia in the CKiD cohort.

Authors:  Rosemary Thomas; Simone Sanna-Cherchi; Bradley A Warady; Susan L Furth; Frederick J Kaskel; Ali G Gharavi
Journal:  Pediatr Nephrol       Date:  2011-03-05       Impact factor: 3.714

Review 5.  Congenital abdominal aortic aneurysm and renal dysplasia.

Authors:  Stephen C W Cheung; Pek-Lan Khong; Wing Chiu; Constantine Metreweli
Journal:  Pediatr Radiol       Date:  2004-04-28

6.  Chronic renal failure in children: a report from Port Harcourt, Nigeria (1985-2000).

Authors:  Ifeoma Anochie; Felicia Eke
Journal:  Pediatr Nephrol       Date:  2003-05-16       Impact factor: 3.714

7.  Growth hormone treatment of renal growth failure during infancy and early childhood.

Authors:  Doris Franke; Miroslav Zivicnjak; Jochen H H Ehrich
Journal:  Pediatr Nephrol       Date:  2009-04-15       Impact factor: 3.714

8.  Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5).

Authors:  Aleksandra M Zurowska; Michel Fischbach; Alan R Watson; Alberto Edefonti; Constantinos J Stefanidis
Journal:  Pediatr Nephrol       Date:  2012-10-09       Impact factor: 3.714

9.  A questionnaire survey of radiological diagnosis and management of renal dysplasia in children.

Authors:  Giovanni Montini; Marco Busutti; Fatos Yalcinkaya; Adrian S Woolf; Stefanie Weber
Journal:  J Nephrol       Date:  2017-06-24       Impact factor: 3.902

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.